These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
468 related articles for article (PubMed ID: 25933462)
1. Partial Oculocutaneous Albinism: Two Siblings with Features of both Hermansky Pudlak and Waardenburg's Syndrome. Ishaq M; Niazi MK; Khan MS; Nadeem Y J Coll Physicians Surg Pak; 2015 Apr; 25 Suppl 1():S43-4. PubMed ID: 25933462 [TBL] [Abstract][Full Text] [Related]
2. Identification of a novel mutation in HPS6 in a patient with hemophilia B and oculocutaneous albinism. O'Brien KJ; Lozier J; Cullinane AR; Osorio B; Nghiem K; Speransky V; Zein WM; Mullikin JC; Neff AT; Simon KL; Malicdan MC; Gahl WA; Young LR; Gochuico BR Mol Genet Metab; 2016 Nov; 119(3):284-287. PubMed ID: 27641950 [TBL] [Abstract][Full Text] [Related]
3. Hermansky-Pudlak syndrome and oculocutaneous albinism in Chinese children with pigmentation defects and easy bruising. Power B; Ferreira CR; Chen D; Zein WM; O'Brien KJ; Introne WJ; Stephen J; Gahl WA; Huizing M; Malicdan MCV; Adams DR; Gochuico BR Orphanet J Rare Dis; 2019 Feb; 14(1):52. PubMed ID: 30791930 [TBL] [Abstract][Full Text] [Related]
4. Syndromic albinism: a review of genetics and phenotypes. Scheinfeld NS Dermatol Online J; 2003 Dec; 9(5):5. PubMed ID: 14996378 [TBL] [Abstract][Full Text] [Related]
5. Posterior staphyloma in oculocutaneous albinism: another possible cause of reduced visual acuity. Lee S; Schimmenti LA; King RA; Brilliant M; Anderson JL; Schoonveld C; Summers CG J AAPOS; 2015 Dec; 19(6):562-4. PubMed ID: 26691042 [TBL] [Abstract][Full Text] [Related]
6. Molecular bases of congenital hypopigmentary disorders in humans and oculocutaneous albinism 1 in Japan. Tomita Y; Miyamura Y; Kono M; Nakamura R; Matsunaga J Pigment Cell Res; 2000; 13 Suppl 8():130-4. PubMed ID: 11041370 [TBL] [Abstract][Full Text] [Related]
7. P gene mutations in patients with oculocutaneous albinism and findings suggestive of Hermansky-Pudlak syndrome. Garrison NA; Yi Z; Cohen-Barak O; Huizing M; Hartnell LM; Gahl WA; Brilliant MH J Med Genet; 2004 Jun; 41(6):e86. PubMed ID: 15173252 [No Abstract] [Full Text] [Related]
8. [Hypomelanoses transmitted from generation to generation]. Otręba M; Buszman E; Miliński M; Wrześniok D Postepy Hig Med Dosw (Online); 2014 Sep; 68():1081-90. PubMed ID: 25228517 [TBL] [Abstract][Full Text] [Related]
9. Severe bleeding with subclinical oculocutaneous albinism in a patient with a novel HPS6 missense variant. Han CG; O'Brien KJ; Coon LM; Majerus JA; Huryn LA; Haroutunian SG; Moka N; Introne WJ; Macnamara E; Gahl WA; Malicdan MCV; Chen D; Krishnan K; Gochuico BR Am J Med Genet A; 2018 Dec; 176(12):2819-2823. PubMed ID: 30369044 [TBL] [Abstract][Full Text] [Related]
10. Biallelic mutations in AP3D1 cause Hermansky-Pudlak syndrome type 10 associated with immunodeficiency and seizure disorder. Mohammed M; Al-Hashmi N; Al-Rashdi S; Al-Sukaiti N; Al-Adawi K; Al-Riyami M; Al-Maawali A Eur J Med Genet; 2019 Nov; 62(11):103583. PubMed ID: 30472485 [TBL] [Abstract][Full Text] [Related]
11. Exome sequencing identifies SLC24A5 as a candidate gene for nonsyndromic oculocutaneous albinism. Wei AH; Zang DJ; Zhang Z; Liu XZ; He X; Yang L; Wang Y; Zhou ZY; Zhang MR; Dai LL; Yang XM; Li W J Invest Dermatol; 2013 Jul; 133(7):1834-40. PubMed ID: 23364476 [TBL] [Abstract][Full Text] [Related]
12. After an initial Hermansky-Pudlak syndrome clinical diagnosis, molecular testing reveals variants for oculocutaneous albinism type 1B: A case report. Serrano-González J; Montes-Rodríguez I; Renta JY; Rojas R; Cadilla CL Mol Genet Genomic Med; 2024 Jul; 12(7):e2493. PubMed ID: 38994739 [TBL] [Abstract][Full Text] [Related]
14. Ocular findings and a comparative study of hair, skin and iris color in Chinese patients with albinism. Arcot Sadagopan K; Teng CH; Hui G; Lin DL Ophthalmic Genet; 2023 Feb; 44(1):54-69. PubMed ID: 36316991 [TBL] [Abstract][Full Text] [Related]
16. Genetics of non-syndromic and syndromic oculocutaneous albinism in human and mouse. Fernández A; Hayashi M; Garrido G; Montero A; Guardia A; Suzuki T; Montoliu L Pigment Cell Melanoma Res; 2021 Jul; 34(4):786-799. PubMed ID: 33960688 [TBL] [Abstract][Full Text] [Related]
17. Color vision in patients with the Hermansky-Pudlak syndrome. Rodríguez JA; Blasini M; Blasini M; Townsend W; Izquierdo NJ Bol Asoc Med P R; 2004; 96(2):84-90. PubMed ID: 15580910 [TBL] [Abstract][Full Text] [Related]
18. Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico. Santiago Borrero PJ; Rodríguez-Pérez Y; Renta JY; Izquierdo NJ; Del Fierro L; Muñoz D; Molina NL; Ramírez S; Pagán-Mercado G; Ortíz I; Rivera-Caragol E; Spritz RA; Cadilla CL J Invest Dermatol; 2006 Jan; 126(1):85-90. PubMed ID: 16417222 [TBL] [Abstract][Full Text] [Related]
19. Clinical and Mutation Spectrum of Autosomal Recessive Non-Syndromic Oculocutaneous Albinism (nsOCA) in Pakistan: A Review. Ullah MI Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741834 [TBL] [Abstract][Full Text] [Related]
20. Clinico-molecular analysis of eleven patients with Hermansky-Pudlak type 5 syndrome, a mild form of HPS. Michaud V; Lasseaux E; Plaisant C; Verloes A; Perdomo-Trujillo Y; Hamel C; Elcioglu NH; Leroy B; Kaplan J; Jouk PS; Lacombe D; Fergelot P; Morice-Picard F; Arveiler B Pigment Cell Melanoma Res; 2017 Jan; 30(6):563-570. PubMed ID: 28640947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]